AbbVie’s priority is to ensure the safety of colleagues and help patients get the medicines they need.

As the tragic events continue to unfold in Ukraine, AbbVie has temporarily suspended operations for all their aesthetics products in Russia.

The company does not have any manufacturing plants in the region. Importantly, AbbVie continues to monitor the safety of their employees in Ukraine and the surrounding region.

AbbVie is doing everything possible to minimize disruption to the treatment and care of their patients and clinical trial participants. The company has paused the start of new clinical studies and the screening and enrollment of clinical trial participants in ongoing studies in Ukraine and Russia. AbbVie is committed to ensuring our clinical trial participants have access to the investigational medicines they need.

AbbVie’s philanthropic focus is on humanitarian, employee, and donation support. The company is:

• Donating a total of 1 million USD to nonprofit partners for medical care and supplies for Ukraine and Ukrainian refugees.
• Donating essential medicines to the Ukrainian government and our disaster relief partners.
• Providing relief and additional financial support as needed to Ukrainian employees and their immediate families.
• Doubling the AbbVie Foundation's employee donation match for select disaster relief partners with active humanitarian relief efforts in Ukraine and surrounding countries.

As this situation evolves, AbbVie will continue working with their nonprofit partners and employees to support relief efforts as they hope for a peaceful resolution.